Zdrowie i gospodarka · 30/01/1996
Bio-Components, Inc. Faces Potential Revocation of FDA Licenses
The FDA is offering a hearing on a proposal to revoke Bio-Components, Inc.'s licenses due to noncompliance with federal biologics regulations, following significant and continued issues with the company's manufacturing processes.